close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

5.52 -4

Strong Buy

Price update 24 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

5.52

Max

5.92

Key metrics

By Trading Economics

Income

4.1M

-33M

Sales

6.1M

44M

EPS

-3.82

Profit margin

-75.213

Employees

279

EBITDA

1.8M

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+134.41% upside

Market Stats

By TradingEconomics

Market Cap

-3.5M

99M

Previous open

9.52

Previous close

5.52

News Sentiment

By Acuity

100%

0%

359 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 lis 2025, 21:54 UTC

Acquisitions, Mergers, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

DJ

Read

24 lis 2025, 18:26 UTC

Major Market Movers

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

DJ

Read

24 lis 2025, 23:49 UTC

Market Talk

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

DJ

Read

24 lis 2025, 23:08 UTC

Market Talk

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

DJ

Read

24 lis 2025, 23:08 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

24 lis 2025, 22:56 UTC

Market Talk
Earnings

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

DJ

Read

24 lis 2025, 22:47 UTC

Market Talk

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

DJ

Read

24 lis 2025, 22:36 UTC

Market Talk
Earnings

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

DJ

Read

24 lis 2025, 22:32 UTC

Earnings

Webco Industries 1Q EPS $6.79 >WEBC

DJ

Read

24 lis 2025, 22:07 UTC

Earnings

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

DJ

Read

24 lis 2025, 22:07 UTC

Earnings

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

DJ

Read

24 lis 2025, 22:06 UTC

Earnings

Couche-Tard 2Q Adj EPS 78c >ATD.T

DJ

Read

24 lis 2025, 22:06 UTC

Earnings

Couche-Tard 2Q Rev $17.9B >ATD.T

DJ

Read

24 lis 2025, 22:06 UTC

Earnings

Couche-Tard 2Q EPS 79c >ATD.T

DJ

Read

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Rev $17.9B >ATD.T

DJ

Read

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Net $740.6M >ATD.T

DJ

Read

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Adj EPS 78c >ATD.T

DJ

Read

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q EPS 79c >ATD.T

DJ

Read

24 lis 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

DJ

Read

24 lis 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

24 lis 2025, 21:44 UTC

Market Talk

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

DJ

Read

24 lis 2025, 21:39 UTC

Acquisitions, Mergers, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

DJ

Read

24 lis 2025, 20:42 UTC

Market Talk

Oil Futures Snap Three-Session Losing Streak -- Market Talk

DJ

Read

24 lis 2025, 20:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

DJ

Read

24 lis 2025, 19:56 UTC

Acquisitions, Mergers, Takeovers

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

DJ

Read

24 lis 2025, 18:26 UTC

Market Talk

Crude Futures Move Higher in Choppy Trade -- Market Talk

DJ

Read

24 lis 2025, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

DJ

Read

24 lis 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

24 lis 2025, 17:09 UTC

Market Talk

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

DJ

Read

24 lis 2025, 16:52 UTC

Acquisitions, Mergers, Takeovers

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

134.41% upside

12 Months Forecast

Average 13.83 USD  134.41%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

359 / 374 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,067.68

↑ +0.83%

JNJ

Johnson and Johnson

205.97

↑ +1.01%

ABBV

AbbVie Inc

229.49

↓-2.82%

UNH

UnitedHealth Group Inc

318.47

↓-0.28%

AZN

AstraZeneca PLC ADR

91.56

↑ +0.6%
help-icon Live chat